Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DBPR108 Multiple Ascending Dose Study in Healthy Male Subjects
NCT02163278Phase 1Completed
- Sponsor
- National Health Research Institutes
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing DBPR108 with matching placebo (2 arms). Primary endpoint: Number of Participants With Adverse Events at 5 weeks. Started Jun 2014; status: completed.
02
Drugs
prusogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02163278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163278.